EID Parry gets USFDA nod for micro-algae facility

Press Trust of India  |  New Delhi 

Murugappa Group firm today said it has received approval from the US Food and Drug Administration (USFDA) for its facility in for organic micro-algae cultivation and processing.

The micro-algae facility is part of its Parry Nutraceuticals division and is located in Oonaiyur, Pudukottai district. It is spread over 130 acres and has 600 tonne per annum capacity.



In a filing, the company said the organic facility has received the Establishment Inspection Report (EIR) from the USFDA following an inspection of the facility in July 2016.

Parry Nutraceuticals Business Head Muthu Murugappan said, "This approval will further enhance our reputation as a leader in micro-algal technology."

He further said that the company is stepping up its new product development (NPD) efforts to meet increasing customer demand for value-added products based on micro-algae.

The company supplies micro-algal health supplements to leading nutraceutical brands in over 35 countries.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

EID Parry gets USFDA nod for micro-algae facility

Murugappa Group firm EID Parry today said it has received approval from the US Food and Drug Administration (USFDA) for its facility in Tamil Nadu for organic micro-algae cultivation and processing. The micro-algae facility is part of its Parry Nutraceuticals division and is located in Oonaiyur, Pudukottai district. It is spread over 130 acres and has 600 tonne per annum capacity. In a BSE filing, the company said the organic facility has received the Establishment Inspection Report (EIR) from the USFDA following an inspection of the facility in July 2016. Parry Nutraceuticals Business Head Muthu Murugappan said, "This approval will further enhance our reputation as a leader in micro-algal technology." He further said that the company is stepping up its new product development (NPD) efforts to meet increasing customer demand for value-added products based on micro-algae. The company supplies micro-algal health supplements to leading nutraceutical brands in ... Murugappa Group firm today said it has received approval from the US Food and Drug Administration (USFDA) for its facility in for organic micro-algae cultivation and processing.

The micro-algae facility is part of its Parry Nutraceuticals division and is located in Oonaiyur, Pudukottai district. It is spread over 130 acres and has 600 tonne per annum capacity.

In a filing, the company said the organic facility has received the Establishment Inspection Report (EIR) from the USFDA following an inspection of the facility in July 2016.

Parry Nutraceuticals Business Head Muthu Murugappan said, "This approval will further enhance our reputation as a leader in micro-algal technology."

He further said that the company is stepping up its new product development (NPD) efforts to meet increasing customer demand for value-added products based on micro-algae.

The company supplies micro-algal health supplements to leading nutraceutical brands in over 35 countries.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22